The study design does try to mitigate blinding issues and expectancy effects, but with half of the participants reporting past use of hallucinogens, this is not going to be very effective blinding.
A majority of your low dose 1st group likely very much realizes that they're on the inactive dose.
A majority of your low dose 1st group likely very much realizes that they're on the inactive dose.